These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35912409)

  • 1. Aspirin Use and Gastric Adenocarcinoma-Reply.
    Ma W; Chan AT
    Cancer Prev Res (Phila); 2022 Aug; 15(8):555. PubMed ID: 35912409
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin Use and Gastric Adenocarcinoma-Letter.
    Lai SW; Hwang BF; Liu CS; Liao KF
    Cancer Prev Res (Phila); 2022 Aug; 15(8):553. PubMed ID: 35912408
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study.
    Epplein M; Nomura AM; Wilkens LR; Henderson BE; Kolonel LN
    Am J Epidemiol; 2009 Aug; 170(4):507-14. PubMed ID: 19584132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.
    Akre K; Ekström AM; Signorello LB; Hansson LE; Nyrén O
    Br J Cancer; 2001 Apr; 84(7):965-8. PubMed ID: 11286478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
    Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.
    Abnet CC; Freedman ND; Kamangar F; Leitzmann MF; Hollenbeck AR; Schatzkin A
    Br J Cancer; 2009 Feb; 100(3):551-7. PubMed ID: 19156150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection by oral phenylalanine against gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
    Iishi H; Tatsuta M; Baba M; Okuda S; Taniguchi H
    Br J Cancer; 1990 Aug; 62(2):173-6. PubMed ID: 2386732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-attributable fractions in gastric cancer risk factors: the necessity to focus on Helicobacter pylori infection.
    Tokudome S; Hosono A; Suzuki S
    Gastric Cancer; 2006; 9(3):240-1. PubMed ID: 16952045
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of
    Watari J; Tomita T; Tozawa K; Oshima T; Fukui H; Miwa H
    Gut Liver; 2020 May; 14(3):281-290. PubMed ID: 31547640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive role of dietary fiber in gastric cardia cancers.
    Roth J; Mobarhan S
    Nutr Rev; 2001 Nov; 59(11):372-4. PubMed ID: 11720343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of endoscopic screening for upper gastrointestinal adenocarcinoma.
    Lagergren J; Ye W; Bergström R; Nyrén O
    JAMA; 2000 Aug 23-30; 284(8):961-2. PubMed ID: 10944640
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach.
    Yamada S; Okamura T; Kobayashi S; Tanaka E; Nakayama J
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1478-84. PubMed ID: 25967588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study.
    Cho MH; Yoo TG; Jeong SM; Shin DW
    Cancer Prev Res (Phila); 2021 Jan; 14(1):95-104. PubMed ID: 32938643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of prostaglandins in the early stage of gastric carcinogenesis induced by N-methyl-N-nitro-N-nitrosoguanidine (MNNG) in rats].
    Silecchia G; Spaziani E; Materia A; Genco A; Scucchi L; Landa García JI; Favalli C; Basso N
    Rev Esp Enferm Apar Dig; 1988 Dec; 74(6):635-9. PubMed ID: 3252383
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option?
    Jiménez P; García A; Santander S; Piazuelo E
    Curr Pharm Des; 2007; 13(22):2261-73. PubMed ID: 17691999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional and metabolic aspects of gastrointestinal cancer.
    Hill MJ
    Curr Opin Clin Nutr Metab Care; 1998 Sep; 1(5):405-7. PubMed ID: 10565384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cimetidine on inhibition by tetragastrin of carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
    Tatsuta M; Iishi H; Yamamura H; Baba M; Yamamoto R; Taniguchi H
    Cancer Res; 1988 Mar; 48(6):1591-5. PubMed ID: 3345530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to Manage a Patient With Gastric Intestinal Metaplasia: An International Perspective.
    Dinis-Ribeiro M; Kuipers EJ
    Gastroenterology; 2020 May; 158(6):1534-1537. PubMed ID: 31926996
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of gastric cancer: a miss.
    Taylor PR
    J Natl Cancer Inst; 2007 Jan; 99(2):101-3. PubMed ID: 17227989
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms.
    Cho SJ; Choi IJ; Kim CG; Lee JY; Nam BH; Kwak MH; Kim HJ; Ryu KW; Lee JH; Kim YW
    Endoscopy; 2012 Feb; 44(2):114-21. PubMed ID: 22271021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.